Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

PHASE4RecruitingINTERVENTIONAL
Enrollment

3,500

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2026

Conditions
Coronary Artery Disease
Interventions
DRUG

Dual antiplatelet therapy with a P2Y12 inhibitor plus aspirin

"Dual antiplatelet therapy with a P2Y12 inhibitor plus aspirin will be given according to the allocated arms in patients undergoing elective percutaneous coronary intervention for complex coronary lesion~1. Prasugrel plus Aspirin arm~2. Clopidogrel plus Aspirin arm"

Trial Locations (2)

06351

RECRUITING

Samsung Medical Center, Seoul

Unknown

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors
collaborator

Inje University Ilsan Paik Hospital

OTHER

collaborator

Seoul St. Mary's Hospital

OTHER

collaborator

Mediplex Sejong Hospital

UNKNOWN

collaborator

Chonnam National University Hospital

OTHER

collaborator

Sejong General Hospital

OTHER

collaborator

Wonkwang University Hospital

OTHER

collaborator

Gachon University Gil Medical Center

OTHER

collaborator

Keimyung University Dongsan Medical Center

OTHER

collaborator

Chungbuk National University Hospital

OTHER

collaborator

Yeungnam University Hospital

OTHER

collaborator

Chungnam National University Hospital

OTHER

collaborator

Wonju Severance Christian Hospital

OTHER

collaborator

Konkuk University Chungju Hospital

UNKNOWN

collaborator

Chung-Ang University Hosptial, Chung-Ang University College of Medicine

OTHER

collaborator

Dankook University

OTHER

collaborator

Incheon St.Mary's Hospital

OTHER

collaborator

Gyeongsang National University Hospital

OTHER

collaborator

Soonchunhyang University Hospital

OTHER

collaborator

Ewha Womans University Seoul Hospital

OTHER

lead

Samsung Medical Center

OTHER